CRISPR-Cas system to discover host-virus interactions in Flaviviridae.

Antiviral strategy CRISPR KO CRISPR/Cas Flaviviridae pathogenesis Flavivirus Genome editing Genome-wide CRISPR screens Host factors Virus-host interactions

Journal

Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645

Informations de publication

Date de publication:
27 10 2023
Historique:
received: 10 03 2023
accepted: 25 10 2023
medline: 30 10 2023
pubmed: 28 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

The Flaviviridae virus family members cause severe human diseases and are responsible for considerable mortality and morbidity worldwide. Therefore, researchers have conducted genetic screens to enhance insight into viral dependency and develop potential anti-viral strategies to treat and prevent these infections. The host factors identified by the clustered regularly interspaced short palindromic repeats (CRISPR) system can be potential targets for drug development. Meanwhile, CRISPR technology can be efficiently used to treat viral diseases as it targets both DNA and RNA. This paper discusses the host factors related to the life cycle of viruses of this family that were recently discovered using the CRISPR system. It also explores the role of immune factors and recent advances in gene editing in treating flavivirus-related diseases. The ever-increasing advancements of this technology may promise new therapeutic approaches with unique capabilities, surpassing the traditional methods of drug production and treatment.

Identifiants

pubmed: 37891676
doi: 10.1186/s12985-023-02216-7
pii: 10.1186/s12985-023-02216-7
pmc: PMC10605781
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

247

Informations de copyright

© 2023. The Author(s).

Références

Cell. 2021 Jan 7;184(1):133-148.e20
pubmed: 33338421
EBioMedicine. 2016 Oct;12:161-169
pubmed: 27688094
Science. 2011 Dec 16;334(6062):1524-9
pubmed: 22096102
Virology. 2005 Jul 20;338(1):53-60
pubmed: 15936793
Elife. 2020 Jan 21;9:
pubmed: 31960794
Biol Pharm Bull. 2016 May 1;39(5):839-48
pubmed: 26887345
Cell. 2020 Mar 5;180(5):956-967.e17
pubmed: 32084332
Autophagy. 2019 May;15(5):922-923
pubmed: 30773971
Nat Methods. 2013 Oct;10(10):977-9
pubmed: 23892898
Sci Rep. 2016 Dec 08;6:38336
pubmed: 27929099
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9527-9532
pubmed: 31019072
mBio. 2017 Jul 18;8(4):
pubmed: 28720733
Nat Methods. 2015 Apr;12(4):326-8
pubmed: 25730490
Chem Rev. 2018 Apr 25;118(8):4448-4482
pubmed: 29652486
Nat Methods. 2012 Feb 19;9(4):363-6
pubmed: 22343343
Trends Parasitol. 2016 Mar;32(3):219-229
pubmed: 26897660
J Virol. 2022 Apr 13;96(7):e0196221
pubmed: 35266803
Nature. 2015 Jan 29;517(7536):583-8
pubmed: 25494202
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Am J Pathol. 2020 Apr;190(4):844-861
pubmed: 32035058
Biochimie. 2020 Aug;175:99-105
pubmed: 32464166
Science. 2016 Aug 5;353(6299):aaf5573
pubmed: 27256883
Nature. 2016 Jul 7;535(7610):159-63
pubmed: 27383987
Nat Biotechnol. 2014 Apr;32(4):347-55
pubmed: 24584096
Nat Microbiol. 2018 Nov;3(11):1214-1223
pubmed: 30224801
Nat Commun. 2022 Jan 10;13(1):105
pubmed: 35013224
J Virol. 2004 Oct;78(19):10543-55
pubmed: 15367621
Semin Cell Dev Biol. 2015 May;41:71-8
pubmed: 25460543
mBio. 2014 Oct 28;5(6):e02012
pubmed: 25352621
Nat Struct Mol Biol. 2004 Oct;11(10):957-62
pubmed: 15334071
Elife. 2019 Sep 13;8:
pubmed: 31516121
Microbiology (Reading). 2005 Mar;151(Pt 3):653-663
pubmed: 15758212
Front Microbiol. 2019 Oct 25;10:2471
pubmed: 31708910
J Glob Infect Dis. 2016 Jan-Mar;8(1):3-15
pubmed: 27013839
J Virol. 2020 Mar 17;94(7):
pubmed: 31915280
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Front Microbiol. 2016 Apr 19;7:496
pubmed: 27148186
Emerg Infect Dis. 2005 Jul;11(7):1021-7
pubmed: 16022775
Nat Rev Microbiol. 2017 Mar;15(3):169-182
pubmed: 28111461
Nat Commun. 2017 Feb 20;8:14516
pubmed: 28218252
Nat Rev Genet. 2022 Jan;23(1):5-22
pubmed: 34363067
Lancet. 2016 Feb 20;387(10020):719-21
pubmed: 26876373
Clin Lab Med. 2010 Mar;30(1):237-60
pubmed: 20513550
Viruses. 2021 Oct 20;13(11):
pubmed: 34834920
Annu Rev Microbiol. 1990;44:649-88
pubmed: 2174669
Nat Rev Genet. 2016 May;17(5):300-12
pubmed: 27087594
Clin Ther. 2017 Aug;39(8):1519-1536
pubmed: 28754189
Proc Natl Acad Sci U S A. 2021 Jun 1;118(22):
pubmed: 34031250
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
Biomed Pharmacother. 2021 Apr;136:111239
pubmed: 33454599
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2241-6
pubmed: 26858407
Nature. 2017 Oct 12;550(7675):280-284
pubmed: 28976959
Cell Mol Life Sci. 2010 Apr;67(8):1353-69
pubmed: 20091084
J Virol. 2019 Jul 30;93(16):
pubmed: 31142667
EMBO Rep. 2018 Sep;19(9):
pubmed: 30126924
Cell. 2014 Oct 23;159(3):635-46
pubmed: 25307933
Cell Rep. 2015 Jul 28;12(4):673-83
pubmed: 26190106
Cell Rep. 2020 Jan 28;30(4):969-983.e4
pubmed: 31956073
Science. 2017 Nov 24;358(6366):1019-1027
pubmed: 29070703
J Clin Virol. 2015 Mar;64:160-73
pubmed: 25453327
mBio. 2023 Apr 25;14(2):e0012723
pubmed: 36809113
Viruses. 2018 Jan 16;10(1):
pubmed: 29337866
J Virol. 2006 Jul;80(14):6964-72
pubmed: 16809302
Front Med (Lausanne). 2021 Mar 03;8:649896
pubmed: 33748164
Annu Rev Genet. 2011;45:273-97
pubmed: 22060043
Nature. 2016 Jul 7;535(7610):164-8
pubmed: 27383988
Science. 2008 Aug 15;321(5891):960-4
pubmed: 18703739
Cells. 2020 Jun 16;9(6):
pubmed: 32560274
J Cell Physiol. 2021 Apr;236(4):2459-2481
pubmed: 32959897
Cell Rep. 2016 Jun 28;16(1):232-246
pubmed: 27342126
J Pharm Sci. 2020 Jan;109(1):62-67
pubmed: 31589876
Viruses. 2019 Jan 06;11(1):
pubmed: 30621318
J Virol. 2021 Nov 23;95(24):e0059621
pubmed: 34586867
Elife. 2019 Sep 17;8:
pubmed: 31526472
Mol Cell. 2019 Dec 5;76(5):826-837.e11
pubmed: 31607545
Nat Methods. 2019 Nov;16(11):1079
pubmed: 31673152
PLoS One. 2016 Jun 28;11(6):e0158364
pubmed: 27352145
Nat Clin Pract Neurol. 2006 May;2(5):264-75
pubmed: 16932563
ACS Nano. 2020 Aug 25;14(8):9243-9262
pubmed: 32697075
Genome Biol. 2015 Nov 09;16:247
pubmed: 26549499
Mol Ther Nucleic Acids. 2020 Mar 6;19:1460-1469
pubmed: 32160714
Nature. 2010 Nov 4;468(7320):67-71
pubmed: 21048762
Science. 2014 Jan 3;343(6166):80-4
pubmed: 24336569
Adv Virus Res. 2016;94:1-51
pubmed: 26997589
Science. 2017 Apr 28;356(6336):438-442
pubmed: 28408723
Nat Cell Biol. 2011 Nov 27;14(1):93-105
pubmed: 22119785
Sci Adv. 2021 Jan 8;7(2):
pubmed: 33523994
Mol Ther Methods Clin Dev. 2021 Jun 11;21:729-740
pubmed: 33969146
Cell. 2014 Oct 23;159(3):647-61
pubmed: 25307932
Adv Immunol. 2017;133:121-169
pubmed: 28215278
Nature. 2011 Mar 31;471(7340):602-7
pubmed: 21455174
Virus Res. 2022 Apr 15;312:198707
pubmed: 35150770
J Virol. 2019 Jul 30;93(16):
pubmed: 31142663
Sci Rep. 2015 Mar 09;5:8865
pubmed: 25746010
Mol Cell. 2015 Nov 5;60(3):385-97
pubmed: 26593719
Nature. 2013 May 9;497(7448):254-7
pubmed: 23584588
J Virol. 1998 Jan;72(1):73-83
pubmed: 9420202
Cell. 2018 Apr 19;173(3):665-676.e14
pubmed: 29551272
J Cell Biol. 2011 Dec 26;195(7):1071-82
pubmed: 22123832
Nat Med. 2019 Feb;25(2):249-254
pubmed: 30692695
Proc Natl Acad Sci U S A. 2015 May 12;112(19):6164-9
pubmed: 25918406
F1000Res. 2015 Aug 25;4:624
pubmed: 26512320
Nat Methods. 2021 May;18(5):499-506
pubmed: 33941935

Auteurs

Zahra Ramezannia (Z)

Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Medical Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Ali Shamekh (A)

Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, 5166/15731, Iran.
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Hossein Bannazadeh Baghi (H)

Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. hbannazadeh@tbzmed.ac.ir.
Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, 5166/15731, Iran. hbannazadeh@tbzmed.ac.ir.
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. hbannazadeh@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH